Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
暂无分享,去创建一个
A. Garden | C. Fuller | R. Weber | L. Peters | D. Rosenthal | W. Morrison | A. Mohamed | A. El-Naggar | Mona Kamal
[1] K. Ang,et al. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] K. Ang,et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. , 2012, International journal of radiation oncology, biology, physics.
[3] C. Grau,et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. , 2010, The Lancet. Oncology.
[4] A. Garden,et al. Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M. Sormani,et al. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study. , 2003, International journal of radiation oncology, biology, physics.
[6] A. Begg,et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation , 2002, British Journal of Cancer.
[7] R. Weber,et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck , 2002, Head & neck.
[8] A. Garden,et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer , 2001 .
[9] H. Withers,et al. Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor. , 1997, International journal of radiation oncology, biology, physics.
[10] A S Garden,et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. , 1993, International journal of radiation oncology, biology, physics.
[11] S. Stringer,et al. Twice‐a‐day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience , 1993, Head & neck.
[12] J. Fowler. The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.
[13] H. Bartelink,et al. The value of postoperative radiotherapy as an adjuvant to radical neck dissection , 1983, Cancer.
[14] G. Fletcher,et al. Analysis of the parameters relating to failures above the clavicles in patients treated by postoperative irradiation for squamous cell carcinomas of the oral cavity or oropharynx. , 1981, International journal of radiation oncology, biology, physics.
[15] R. Marcus,et al. Postoperative irradiation for squamous cell carcinomas of the head and neck: analysis of time-dose factors related to control above the clavicles. , 1979, International journal of radiation oncology, biology, physics.
[16] F. Eschwège,et al. Combination of radiotherapy and surgery in the treatment of head and neck cancers. , 1975, Cancer treatment reviews.
[17] G. Fletcher,et al. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. , 1972, American journal of surgery.
[18] Fletcher Gh,et al. Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers. , 1957 .
[19] Jacques Bernier,et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.
[20] R. Spiro,et al. Failure at the primary site following multimodality treatment in advanced head and neck cancer. , 1984, Head & neck surgery.
[21] G. Fletcher. Textbook of radiotherapy , 1973 .